Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
4.220
-0.080 (-1.86%)
Sep 8, 2026, 2:37 PM EDT - Market open
Bicycle Therapeutics Market Cap
Bicycle Therapeutics has a market cap or net worth of $295.37 million as of September 8, 2026. Its market cap has decreased by -40.48% in one year.
Market Cap
295.37M
Enterprise Value
-200.02M
1-Year Change
-40.48%
Ranking
Category
Stock Price
$4.22
ChartMarket Cap Chart
Since May 23, 2019, Bicycle Therapeutics's market cap has increased from $212.36M to $295.37M, an increase of 39.09%. That is a compound annual growth rate of 4.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 295.37M | -39.86% |
| Dec 31, 2025 | 491.12M | -49.19% |
| Dec 31, 2024 | 966.64M | 26.03% |
| Dec 29, 2023 | 766.98M | -12.72% |
| Dec 30, 2022 | 878.81M | -50.89% |
| Dec 31, 2021 | 1.79B | 367.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vicore Pharma Holding AB | 320.75M |
| Immuneering | 311.84M |
| Orchestra BioMed Holdings | 305.33M |
| Fate Therapeutics | 297.15M |
| Clinuvel Pharmaceuticals | 296.25M |
| Fulcrum Therapeutics | 293.74M |
| Foghorn Therapeutics | 292.18M |
| ProQR Therapeutics | 292.12M |